Invacare gains on FDA settlement, supplies biz sale

December 21, 2012 by MassDevice staff

Invacare shares are up today after the medical device company settles a beef with the FDA and ditches its Invacare Supply Group business for $150 million.


Invacare (NYSE:IVC) agreed to a consent decree with the FDA that will temporarily shutter 2 facilities in Ohio and the divestiture of its medical supplies business for $150 million, sending shares up more than 2% today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.